SK279319B6 - 5-(subst.amino)-8-(fenyl alebo subst.fenyl)-3h, 6h - Google Patents

5-(subst.amino)-8-(fenyl alebo subst.fenyl)-3h, 6h Download PDF

Info

Publication number
SK279319B6
SK279319B6 SK1055-89A SK105589A SK279319B6 SK 279319 B6 SK279319 B6 SK 279319B6 SK 105589 A SK105589 A SK 105589A SK 279319 B6 SK279319 B6 SK 279319B6
Authority
SK
Slovakia
Prior art keywords
phenyl
trifluoromethyl
tetraazaacenaphthylen
stirred
added
Prior art date
Application number
SK1055-89A
Other languages
English (en)
Slovak (sk)
Other versions
SK105589A3 (en
Inventor
Joseph W. Epstein
Jeremy I. Levin
Shin Shyong Tseng
Original Assignee
American Cyanamid Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Company filed Critical American Cyanamid Company
Publication of SK279319B6 publication Critical patent/SK279319B6/sk
Publication of SK105589A3 publication Critical patent/SK105589A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/16Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SK1055-89A 1988-02-22 1989-02-17 5-(subst.amino)-8-(phenyl or subst.phenyl)-3h,6h-1,4,5a,8a- -tetraazaacenaphtylen-3-ones and manufacturing process thereof SK105589A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15844888A 1988-02-22 1988-02-22

Publications (2)

Publication Number Publication Date
SK279319B6 true SK279319B6 (sk) 1998-09-09
SK105589A3 SK105589A3 (en) 1998-09-09

Family

ID=22568168

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1055-89A SK105589A3 (en) 1988-02-22 1989-02-17 5-(subst.amino)-8-(phenyl or subst.phenyl)-3h,6h-1,4,5a,8a- -tetraazaacenaphtylen-3-ones and manufacturing process thereof

Country Status (23)

Country Link
EP (1) EP0329940B1 (de)
JP (1) JP2641556B2 (de)
KR (1) KR970009226B1 (de)
AR (1) AR247211A1 (de)
AT (1) ATE99686T1 (de)
AU (1) AU611769B2 (de)
CA (1) CA1329594C (de)
CZ (1) CZ284273B6 (de)
DD (1) DD283624A5 (de)
DE (1) DE68911951T2 (de)
DK (1) DK172397B1 (de)
ES (1) ES2061739T3 (de)
FI (1) FI89922C (de)
HU (1) HU203554B (de)
IE (1) IE64147B1 (de)
IL (1) IL88974A (de)
NO (1) NO169589C (de)
NZ (1) NZ228009A (de)
PH (1) PH26358A (de)
PL (1) PL158865B1 (de)
PT (1) PT89766B (de)
SK (1) SK105589A3 (de)
ZA (1) ZA891310B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5013737A (en) * 1988-02-22 1991-05-07 American Cyanamid Company 2,4,8-Trisubstituted-3H,6H-1,4,5A,8A-tetraazaacenaphtylene-3,5-(4H)-diones and 2,4-8-trisubstituted-4,5-dihydro-5-thioxo-3H,6H-1,4,5A,8A-tetrazaacenaphthylen-3-ones
EP0562236A1 (de) * 1992-03-26 1993-09-29 American Cyanamid Company Verfahren zur Synthese von 5-((substituierte)-Amino)-8-(Phenyl oder substituierte Phenyl)-3H,6H-1,4,5a,8a-Tetraazaacenaphthylen-3-Onen
EP0957918A1 (de) * 1996-12-19 1999-11-24 American Cyanamid Company Verfahren zur behandlung oder unterdrückung von neutropenie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4236005A (en) * 1979-07-02 1980-11-25 American Cyanamid Company Imidazo[1,5-a]pyrimidines
US4713383A (en) * 1984-10-01 1987-12-15 Ciba-Geigy Corporation Triazoloquinazoline compounds, and their methods of preparation, pharmaceutical compositions, and uses
US4576943A (en) * 1984-10-09 1986-03-18 American Cyanamid Company Pyrazolo[1,5-a]pyrimidines
EP0264773A1 (de) * 1986-10-16 1988-04-27 American Cyanamid Company 4,5-Dihydro- und 4,5,6,7-Tetrahydropyrazolo[1,5-a]pyrimidine

Also Published As

Publication number Publication date
ZA891310B (en) 1989-11-29
PT89766B (pt) 1994-03-31
EP0329940B1 (de) 1994-01-05
HU203554B (en) 1991-08-28
DK79589D0 (da) 1989-02-21
JP2641556B2 (ja) 1997-08-13
IL88974A (en) 1993-03-15
CA1329594C (en) 1994-05-17
JPH01249774A (ja) 1989-10-05
KR970009226B1 (en) 1997-06-09
CZ105589A3 (cs) 1998-07-15
FI890826A (fi) 1989-08-23
NO169589B (no) 1992-04-06
PL158865B1 (pl) 1992-10-30
DE68911951T2 (de) 1994-06-01
KR890013022A (ko) 1989-09-20
DK172397B1 (da) 1998-05-18
AR247211A1 (es) 1994-11-30
PT89766A (pt) 1989-10-04
EP0329940A1 (de) 1989-08-30
FI890826A0 (fi) 1989-02-21
IE64147B1 (en) 1995-07-12
NZ228009A (en) 1991-09-25
FI89922B (fi) 1993-08-31
IE890543L (en) 1989-08-22
IL88974A0 (en) 1989-08-15
ES2061739T3 (es) 1994-12-16
DE68911951D1 (de) 1994-02-17
AU611769B2 (en) 1991-06-20
DK79589A (da) 1989-08-23
PH26358A (en) 1992-04-29
AU3017289A (en) 1989-08-24
PL277837A1 (en) 1989-11-13
FI89922C (fi) 1993-12-10
SK105589A3 (en) 1998-09-09
CZ284273B6 (cs) 1998-10-14
NO890724D0 (no) 1989-02-21
HUT51626A (en) 1990-05-28
NO890724L (no) 1989-08-23
DD283624A5 (de) 1990-10-17
ATE99686T1 (de) 1994-01-15
NO169589C (no) 1992-07-15

Similar Documents

Publication Publication Date Title
SK398A3 (en) Pyrrolopyrimidines and processes for the preparation thereof
IL98316A (en) 2-Tauril-5-Transformed-1,2, 4-Triazolo] A-1,5 [] 1,3,5 [Triazine-7 Amines and 7-Troaril-2-Transformed Pirazolo] A-1,5 [] 1, 3,5 [triazine-4 amines process to prepare
EP2576561A1 (de) Heterocyclische verbindungen als januskinasehemmer
DE60301339T2 (de) Pyrazolopyrimidin- und pyrazolotriazinderivate und diese enthaltende pharmazeutische zubereitungen
EP0241682B1 (de) Benzodiazepinderivate und ihre Herstellung und Verwendung
CA2658404A1 (en) Selective antagonists of a2a adenosine receptors
RU2093513C1 (ru) Производные 9-деазагуанины или их таутомеры и фармацевтическая композиция, обладающая способностью ингибировать активность пуриннуклеозид фосфорилазы у млекопитающих
US4904658A (en) Substituted-6H,8H-pyrimido-[1,2,3-cd]purine-8,10-(9H)-diones and substituted-6H,10H-pyrimido[1,2-cd]purin-10-ones
EP0978517A2 (de) Triazolpurine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US4916137A (en) 5-(Substituted-amino)-8-(phenyl or substituted-phenyl)-3H,6H-1,4,5A,8A-tetraazaacenaphthylen-3-ones and treatment of neural behavior disorders
SK279319B6 (sk) 5-(subst.amino)-8-(fenyl alebo subst.fenyl)-3h, 6h
EP0443312B1 (de) 3H,6H-1,4,5a,8a-Tetraazaacenaphthylen-3,5-(4H)dione
EP0573659B1 (de) Pyrazolothiazolopyrimidin-derivate
WO2001003644A9 (en) Pyrazolopyrimidinone derivatives conjugated to thiophene moieties or benzo [fused] 5-membered heterocycles for erectile dysfunction
US4871732A (en) Substituted imidazo(2,1-b)quinazolin-5(3H)-ones and related tricyclic compounds and use as bronchodilators
NO314760B1 (no) Pyrazolo(3,4-d)pyrimidiner, fremgangsmåte for fremstilling, farmasöytiske sammensetninger inneholdende disse, samt anvendelse av pyrimidinene
EP0957918A1 (de) Verfahren zur behandlung oder unterdrückung von neutropenie